Tubidy
    Machine learning is changing the way we do science at Novartis

    Machine learning is changing the way we do science at Novartis

    00:38 |
    Download MP3

    Related Videos

    Novartis CEO: Our leukemia drug Scemblix is a potential $3 billion plus medicine 4:43

    Novartis CEO: Our leukemia drug Scemblix is a potential $3 billion plus medicine

    Novartis Research & Development 3:01

    Novartis Research & Development

    Novartis CEO discusses how AI will impact drug development 6:51

    Novartis CEO discusses how AI will impact drug development

    Novartis Cancer Drug Is Approved With $475,000 Price Tag 1:13

    Novartis Cancer Drug Is Approved With $475,000 Price Tag

    Novartis as a focused innovative medicines company 0:54

    Novartis as a focused innovative medicines company

    Novartis mission 1:16

    Novartis mission

    Novartis Oncology - BOLD Science. Transforming Lives. Striving For Cures. 0:59

    Novartis Oncology - BOLD Science. Transforming Lives. Striving For Cures.

    Novartis, Sandoz recall 12 medications over packaging concerns 0:34

    Novartis, Sandoz recall 12 medications over packaging concerns

    25 Years of Novartis – Continuing our innovation journey 2:59

    25 Years of Novartis – Continuing our innovation journey

    Long Live Life: Connecting with the Novartis Mission 1:40

    Long Live Life: Connecting with the Novartis Mission

    Manufacturing CAR-T Cell Therapies: The Novartis Approach 2:14

    Manufacturing CAR-T Cell Therapies: The Novartis Approach

    Corporate responsibility at Novartis 1:37

    Corporate responsibility at Novartis

    Novartis Financial Results Q3 2019 5:48

    Novartis Financial Results Q3 2019

    Machine learning is changing the way we do science at Novartis 0:39

    Machine learning is changing the way we do science at Novartis

    Novartis in 360 Ɩ Tour our Compound Library 0:44

    Novartis in 360 Ɩ Tour our Compound Library

    Working with Multiple Sclerosis – A Novartis Intern’s Experience 0:55

    Working with Multiple Sclerosis – A Novartis Intern’s Experience

    Novartis Full Year Results 2019 3:52

    Novartis Full Year Results 2019

    Our Common Portrait. Associates of Novartis Global Service Center in Prague. 1:43

    Our Common Portrait. Associates of Novartis Global Service Center in Prague.

    FDA approves Novartis gene therapy for rare genetic disorder 1:01

    FDA approves Novartis gene therapy for rare genetic disorder

    Novartis in 360 Ɩ Experience how we are making SENSE of Big Data 0:22

    Novartis in 360 Ɩ Experience how we are making SENSE of Big Data